Lp-PLA2 (Lipoprotein-Associated Phospholipase A2) Deficiency Lowers Cholesterol Levels and Protects Against Atherosclerosis in Rabbits

被引:6
|
作者
Chen, Jiahuan [1 ]
Zhang, Huanyu [1 ]
Li, Linquan [1 ]
Zhang, Xinwei [1 ]
Zhao, Dazhong [1 ]
Wang, Lingyu [1 ]
Wang, Jiaqi [1 ]
Yang, Ping [1 ,2 ]
Sun, Huan [2 ]
Liu, Kun [2 ]
Chen, Weiwei [2 ]
Li, Lin
Lin, Feng [1 ]
Li, Zhanjun [1 ]
Chen, Y. Eugene [4 ]
Zhang, Jifeng [4 ]
Pang, Daxin [1 ,5 ]
Ouyang, Hongsheng [1 ,5 ]
He, Yuquan [2 ,8 ]
Fan, Jianglin [3 ,7 ]
Tang, Xiaochun [1 ,5 ,6 ]
机构
[1] Jilin Univ, Coll Anim Sci, Changchun, Jilin, Peoples R China
[2] Jilin Univ, Dept Cardiol, China Japan Union Hosp, Changchun, Peoples R China
[3] Univ Yamanashi, Fac Med, Grad Sch Med Sci, Dept Mol Pathol, Kofu, Yamanashi, Japan
[4] Univ Michigan, Ctr Adv Models Translat Sci & Therapeut, Dept Internal Med, Med Ctr, Ann Arbor, MI USA
[5] Jilin Univ, Chongqing Res Inst, Chongqing, Peoples R China
[6] Jilin Univ, Coll Anim Sci, 5333 Xian Rd, Changchun, Peoples R China
[7] Univ Yamanashi, Fac Med, Grad Sch Med Sci, Dept Mol Pathol, Kofu, Yamanashi, Japan
[8] Jilin Univ, Dept Cardiol, China Japan Union Hosp, Changchun, Peoples R China
基金
国家重点研发计划;
关键词
atherosclerosis; cardiovascular diseases; inflammation; lipoproteins; rabbits; ACTIVATING-FACTOR-ACETYLHYDROLASE; CORONARY-ARTERY-DISEASE; PAF-AH ACTIVITY; IMPROVES HYPERLIPIDEMIA; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DARAPLADIB; RISK; INFLAMMATION; EVENTS;
D O I
10.1161/ATVBAHA.122.317898
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Elevated plasma Lp-PLA(2) (lipoprotein-associated phospholipase A(2)) activity is closely associated with an increased risk of cardiovascular events. However, whether and how Lp-PLA(2) is directly involved in the pathogenesis of atherosclerosis is still unclear. To examine the hypothesis that Lp-PLA(2) could be a potential preventative target of atherosclerosis, we generated Lp-PLA(2) knockout rabbits and investigated the pathophysiological functions of Lp-PLA(2). Methods:Lp-PLA(2) knockout rabbits were generated using CRISPR/Cas9 system to assess the role of Lp-PLA(2) in plasma lipids regulation and identify its underlying molecular mechanisms. Homozygous knockout rabbits along with wild-type rabbits were fed a cholesterol-rich diet for up to 14 weeks and their atherosclerotic lesions were compared. Moreover, the effects of Lp-PLA(2) deficiency on the key cellular behaviors in atherosclerosis were assessed in vitro. Results:When rabbits were fed a standard diet, Lp-PLA(2) deficiency led to a significant reduction in plasma lipids. The decreased protein levels of SREBP2 (sterol regulatory element-binding protein 2) and HMGCR (3-hydroxy-3-methylglutaryl coenzyme A reductase) in livers of homozygous knockout rabbits indicated that the cholesterol biosynthetic pathway was impaired with Lp-PLA(2) deficiency. In vitro experiments further demonstrated that intracellular Lp-PLA(2) efficiently enhanced SREBP2-related cholesterol biosynthesis signaling independently of INSIGs (insulin-induced genes). When fed a cholesterol-rich diet, homozygous knockout rabbits exhibited consistently lower level of hypercholesterolemia, and their aortic atherosclerosis lesions were significantly reduced by 60.2% compared with those of wild-type rabbits. The lesions of homozygous knockout rabbits were characterized by reduced macrophages and the expression of inflammatory cytokines. Macrophages of homozygous knockout rabbits were insensitive to M1 polarization and showed reduced DiI-labeled lipoprotein uptake capacity compared with wild-type macrophages. Lp-PLA(2) deficiency also inhibited the adhesion between monocytes and endothelial cells. Conclusions:These results demonstrate that Lp-PLA(2) plays a causal role in regulating blood lipid homeostasis and Lp-PLA(2) deficiency protects against dietary cholesterol-induced atherosclerosis in rabbits. Lp-PLA(2) could be a potential target for the prevention of atherosclerosis.
引用
收藏
页码:E11 / E28
页数:18
相关论文
共 50 条
  • [21] Lipoprotein-associated phospholipase A2 (Lp-PLA2): A novel and promising biomarker for cardiovascular risks assessment
    Cai, Anping
    Zheng, Dongdan
    Qiu, Ruofeng
    Mai, Weiyi
    Zhou, Yingling
    DISEASE MARKERS, 2013, 34 (05) : 323 - 331
  • [22] Characterising the role of lipoprotein-associated phospholipase A2 (Lp-PLA2) in experimental autoimmune uveoretinitis (EAU)
    Beers, Gemma
    Boldison, Joanne
    Copland, David Alexander
    Adamson, Peter S.
    Nicholson, Lindsay B.
    Dick, Andrew D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [23] twin study of heritability of plasma Lipoprotein-associated Phospholipase A2 (Lp-PLA2) mass and activity
    Rossi, G. P.
    Lenzini, L.
    Antezza, K.
    Brasilina, C.
    Wolfert, R. L.
    Nelson, J. J.
    Cesari, M.
    Narkiewicz, K.
    Williams, C. J.
    EUROPEAN HEART JOURNAL, 2008, 29 : 628 - 628
  • [24] A twin study of heritability of plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) mass and activity
    Lenzini, Livia
    Antezza, Katia
    Caroccia, Brasilina
    Wolfert, Robert L.
    Szczech, Radoslaw
    Cesari, Maurizio
    Narkiewicz, Krzysztof
    Williams, Christopher J.
    Rossi, Gian Paolo
    ATHEROSCLEROSIS, 2009, 205 (01) : 181 - 185
  • [25] Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker
    Vittos, Oana
    Toana, Bogdan
    Vittos, Alexandros
    Moldoveanu, Elena
    BIOMARKERS, 2012, 17 (04) : 289 - 302
  • [26] Heritability of Plasma Lipoprotein-associated Phospholipase A2 (Lp-PLA2), a new marker of cardiovascular risk
    Lenzini, L.
    Caroccia, B.
    Wolfert, R.
    Szczech, R.
    Cesari, M.
    Narkiewicz, K.
    Williams, C. J.
    Rossi, G. P.
    HYPERTENSION, 2008, 52 (04) : 764 - 764
  • [27] The effect of percutaneous coronary intervention on transcoronary lipoprotein-associated phospholipase A2 (LP-PLA2) concentration
    Munir, M. S.
    Ahmed, A. H.
    Brewer, M. A.
    Shankar, K. J.
    Williams, S.
    Casscells, S. W.
    Wilson, J. M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 40 (06) : 898 - 899
  • [28] Characterising the role of lipoprotein-associated phospholipase A2 (Lp-PLA2) in experimental autoimmune uveoretinitis (EAU)
    Beers, G.
    Boldison, J.
    Copland, D.
    Adamson, P.
    Nicholson, L.
    Dick, A.
    IMMUNOLOGY, 2013, 140 : 51 - 51
  • [29] THE VALUE OF PLASMA LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) LEVELS IN THE DIAGNOSIS OF SUSPECTED CORONARY HEART DISEASE (CHD)
    Yanmin, X.
    Zhanqian, C.
    HEART, 2015, 101 : A1 - A1
  • [30] Lipoprotein-associated phospholipase A2 and atherosclerosis
    Wilensky, Robert L.
    Macphee, Colin H.
    CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (05) : 415 - 420